NEW YORK (GenomeWeb News) – The Australian Research Council has awarded several new grants to researchers at the Walter and Eliza Hall Institute in Melbourne to pursue genetic and genomic studies aimed at breast cancer, inflammatory diseases, and chronic pain.
The ARC Discovery Project grants on average provide around AU$116,000 ($105,000) per year over three years. Three of the Hall Institute researchers to receive ARC funding also won QEII Fellowships, which are funded over five years.
The studies will include a collaboration with LaTrobe University that will focus on the role of a protein in cancer, and a collaboration with the University of Melbourne that will study small molecule structures and protein interactions involved in diseases.
Another Hall Institute study will explore genes that shut off immune responses, and another will seek to identify genes involved in breast cancer progression.
"From research into the epigenetic modifiers that control whether our genes are switched off or on to developing an understanding of what goes wrong with our immune systems to allow inflammatory diseases such as rheumatoid arthritis and psoriasis to occur, our scientists are striving to find the causes, treatments, and cures that will benefit people worldwide," Hall Institute Director Doug Hilton said in a statement.